Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | EDNRB | P24530 | 1/20 | 0.35 |
| ▸ | EDNRA | P25101 | 1/20 | 0.35 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19009395 | 1.00 | ATM (0.35) | ATMKDM4EL3MBTL1EDNRBEDNRA | |
| SCHEMBL19035942 | 1.00 | ATM (0.35) | ATMKDM4EL3MBTL1EDNRBEDNRA | |
| SCHEMBL19035996 | 0.99 | ATM (0.36) | ATMKDM4EL3MBTL1EDNRBEDNRA | |
| SCHEMBL19035968 | 0.98 | ATM (0.37) | ATMKDM4EL3MBTL1EDNRBEDNRA | |
| SCHEMBL19036003 | 0.97 | EDNRB (0.35) | ATMKDM4EL3MBTL1EDNRBEDNRA | |
| SCHEMBL19035998 | 0.94 | ATM (0.35) | ATMKDM4EL3MBTL1EDNRBEDNRA | |
| SCHEMBL19009421 | 0.93 | L3MBTL1 (0.42) | ATMKDM4EL3MBTL1EDNRBEDNRA | |
| SCHEMBL19035973 | 0.93 | L3MBTL1 (0.42) | ATMKDM4EL3MBTL1EDNRBEDNRA | |
| SCHEMBL19036001 | 0.93 | ATM (0.36) | ATMKDM4EL3MBTL1EDNRBEDNRA | |
| SCHEMBL19035956 | 0.92 | EDNRB (0.32) | ATMKDM4EL3MBTL1EDNRBEDNRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10336772-B2 | Bicarbazole compound, material for organic light-emitting device including bicarbazole compound, and organic light-emitting device including bicarbazole compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-02 | — | — | US | disclosed |
| US-20170183360-A1 | BICARBAZOLE COMPOUND, MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-06-29 | — | — | US | disclosed |
| US-20170183360-A1 | BICARBAZOLE COMPOUND, MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10336772-B2 | Bicarbazole compound, material for organic light-emitting device including bicarbazole compound, and organic light-emitting device including bicarbazole compound | BRD1, CYP1B1, ARL1 | ATM 986/4885KDM4E 4064/4885L3MBTL1 251/4885 |
| US-20170183360-A1 | BICARBAZOLE COMPOUND, MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND | BRD1, CYP1B1, ARL1 | ATM 986/4885KDM4E 4064/4885L3MBTL1 251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.